Use of Public Research and Manufacturing Enterprises to Lower Prescription Drug Prices and Increase Innovation

Journal of Law, Medicine and Ethics 52 (3):750-754 (2024)
  Copy   BIBTEX

Abstract

This article proposes building on the success of publicly funded drug research and development and expanding the model to include the full cycle development, testing, manufacture and distribution of innovative and affordable new drugs.

Other Versions

No versions found

Links

PhilArchive

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Addressing High Drug Prices by Reforming Pharmacy Benefit Managers.Benjamin N. Rome - 2023 - Journal of Law, Medicine and Ethics 51 (S2):46-51.

Analytics

Added to PP
2024-12-17

Downloads
31 (#1,576,690)

6 months
5 (#1,609,967)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references